Option Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by State of Alaska Department of Revenue

State of Alaska Department of Revenue lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 3.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,871 shares of the company’s stock after acquiring an additional 735 shares during the quarter. State of Alaska Department of Revenue’s holdings in Option Care Health were worth $621,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in OPCH. Wealth Enhancement Advisory Services LLC purchased a new stake in Option Care Health in the third quarter valued at $206,000. International Assets Investment Management LLC boosted its stake in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after buying an additional 2,757 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after acquiring an additional 1,446 shares during the period. Raymond James & Associates raised its position in Option Care Health by 6.3% during the third quarter. Raymond James & Associates now owns 85,279 shares of the company’s stock valued at $2,669,000 after acquiring an additional 5,049 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in Option Care Health by 37.2% in the third quarter. Blue Trust Inc. now owns 4,022 shares of the company’s stock valued at $126,000 after acquiring an additional 1,091 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling at Option Care Health

In other news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. JMP Securities raised their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $38.00 to $27.00 in a research report on Monday. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, Barrington Research reduced their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Stock Down 2.4 %

OPCH opened at $22.93 on Friday. The company has a market cap of $3.90 billion, a PE ratio of 19.27, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. Option Care Health, Inc. has a twelve month low of $22.25 and a twelve month high of $34.63. The company has a 50-day moving average price of $29.98 and a 200 day moving average price of $29.74. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.